U.S. Physical Therapy, Inc.

Report azionario NYSE:USPH

Capitalizzazione di mercato: US$932.9m

U.S. Physical Therapy Crescita futura

Criteri Future verificati 3/6

Si prevede che U.S. Physical Therapy aumenterà gli utili e i ricavi rispettivamente del 47.5% e 7.3% all'anno, mentre si prevede che l'EPS crescerà del 52.4% all'anno.

Informazioni chiave

47.5%

Tasso di crescita degli utili

52.36%

Tasso di crescita dell'EPS

Healthcare crescita degli utili19.0%
Tasso di crescita dei ricavi7.3%
Rendimento futuro del capitale proprion/a
Copertura analitica

Good

Ultimo aggiornamento21 May 2026

Aggiornamenti recenti sulla crescita futura

Articolo di analisi Mar 01

U.S. Physical Therapy, Inc. Just Missed EPS By 21%: Here's What Analysts Think Will Happen Next

Last week, you might have seen that U.S. Physical Therapy, Inc. ( NYSE:USPH ) released its yearly result to the market...

Recent updates

Aggiornamento della narrazione May 30

USPH: Hospital Alliances And Medicare Pricing Will Drive Future Margin Recovery

Analysts have trimmed their blended price target on U.S. Physical Therapy from about $107 to roughly $94, reflecting lower P/E assumptions and somewhat softer profitability expectations, along with higher net debt. They also note potential margin improvement supported by hospital alliances and improved Medicare rates.
Seeking Alpha May 22

U.S. Physical Therapy: The Valuation Reset Changes The Story (Rating Upgrade)

Summary U.S. Physical Therapy, Inc. has seen valuation multiples compress significantly despite continued revenue growth and new strategic initiatives. U.S. Physical Therapy reported Q1 2026 revenue of $198.3M (+7.9% YoY) but missed EPS expectations due to higher costs from acquisitions and clinic startups. Management is pursuing hospital partnerships and shifting toward private insurance, aiming to boost clinic utilization and reduce reliance on Medicare/Medicaid. I now rate U.S. Physical Therapy as hold, reflecting improved risk/reward at current valuation but acknowledging persistent structural challenges and margin pressures. Read the full article on Seeking Alpha
Articolo di analisi Sep 12

These 4 Measures Indicate That U.S. Physical Therapy (NYSE:USPH) Is Using Debt Reasonably Well

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...
Articolo di analisi Aug 02

Pinning Down U.S. Physical Therapy, Inc.'s (NYSE:USPH) P/E Is Difficult Right Now

When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") below 17x, you may...
Articolo di analisi Jul 11

U.S. Physical Therapy (NYSE:USPH) Is Reinvesting At Lower Rates Of Return

If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Ideally, a...
Articolo di analisi Jun 10

Here's Why U.S. Physical Therapy (NYSE:USPH) Can Manage Its Debt Responsibly

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...
Articolo di analisi May 14

Here's Why It's Unlikely That U.S. Physical Therapy, Inc.'s (NYSE:USPH) CEO Will See A Pay Rise This Year

Key Insights U.S. Physical Therapy's Annual General Meeting to take place on 20th of May CEO Chris Reading's total...
Articolo di analisi Mar 24

Should You Think About Buying U.S. Physical Therapy, Inc. (NYSE:USPH) Now?

U.S. Physical Therapy, Inc. ( NYSE:USPH ), might not be a large cap stock, but it received a lot of attention from a...
Articolo di analisi Mar 01

U.S. Physical Therapy, Inc. Just Missed EPS By 21%: Here's What Analysts Think Will Happen Next

Last week, you might have seen that U.S. Physical Therapy, Inc. ( NYSE:USPH ) released its yearly result to the market...
Articolo di analisi Feb 28

U.S. Physical Therapy (NYSE:USPH) Seems To Use Debt Quite Sensibly

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...
Articolo di analisi Jan 03

Capital Allocation Trends At U.S. Physical Therapy (NYSE:USPH) Aren't Ideal

If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. In a perfect...
Articolo di analisi Nov 09

Shareholders Should Be Pleased With U.S. Physical Therapy, Inc.'s (NYSE:USPH) Price

When close to half the companies in the Healthcare industry in the United States have price-to-sales ratios (or "P/S...
User avatar
Nuova narrazione Sep 14

Tactical Contract Renegotiations And Innovative Recruitment Tactics Propel Revenue Growth And Margin Expansion

Innovations in recruitment and operational efficiencies are set to bolster net margins despite a tight labor market and high costs.
Articolo di analisi Aug 07

U.S. Physical Therapy (NYSE:USPH) Might Be Having Difficulty Using Its Capital Effectively

If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Firstly, we'll...
Articolo di analisi Jul 17

U.S. Physical Therapy (NYSE:USPH) Has A Rock Solid Balance Sheet

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Articolo di analisi Jun 04

U.S. Physical Therapy, Inc.'s (NYSE:USPH) Business Is Trailing The Industry But Its Shares Aren't

When you see that almost half of the companies in the Healthcare industry in the United States have price-to-sales...
Articolo di analisi May 21

There May Be Reason For Hope In U.S. Physical Therapy's (NYSE:USPH) Disappointing Earnings

The market for U.S. Physical Therapy, Inc.'s ( NYSE:USPH ) shares didn't move much after it posted weak earnings...
Articolo di analisi May 11

U.S. Physical Therapy (NYSE:USPH) Is Due To Pay A Dividend Of $0.44

The board of U.S. Physical Therapy, Inc. ( NYSE:USPH ) has announced that it will pay a dividend of $0.44 per share on...
Articolo di analisi May 05

Returns On Capital Signal Tricky Times Ahead For U.S. Physical Therapy (NYSE:USPH)

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...
Articolo di analisi Apr 21

A Look At The Fair Value Of U.S. Physical Therapy, Inc. (NYSE:USPH)

Key Insights Using the 2 Stage Free Cash Flow to Equity, U.S. Physical Therapy fair value estimate is US$113 U.S...
Articolo di analisi Apr 07

Is Now The Time To Look At Buying U.S. Physical Therapy, Inc. (NYSE:USPH)?

While U.S. Physical Therapy, Inc. ( NYSE:USPH ) might not have the largest market cap around , it saw a decent share...
Articolo di analisi Mar 04

U.S. Physical Therapy, Inc.'s (NYSE:USPH) Shareholders Might Be Looking For Exit

When you see that almost half of the companies in the Healthcare industry in the United States have price-to-sales...
Articolo di analisi Dec 23

The Returns On Capital At U.S. Physical Therapy (NYSE:USPH) Don't Inspire Confidence

What trends should we look for it we want to identify stocks that can multiply in value over the long term? Ideally, a...
Articolo di analisi Dec 07

Why U.S. Physical Therapy, Inc. (NYSE:USPH) Could Be Worth Watching

While U.S. Physical Therapy, Inc. ( NYSE:USPH ) might not be the most widely known stock at the moment, it saw a...
Seeking Alpha Oct 13

U.S. Physical Therapy: Positioned For Market Dominance Amidst Attractive Valuations

Summary USPH has a substantial presence in the physical therapy industry, with 662 clinics in 41 states, particularly Texas and Tennessee. Acquisitions, primarily through partnership models, are central to USPH's growth strategy. The company expanded into the IIP sector in 2017 and has made several acquisitions. The U.S. rehab market is projected to exceed $40 billion by 2025, driven by demographic trends like an aging population, rising obesity, and a focus on cost-effective healthcare. Physical therapy has demonstratedcost-effectiveness in patient care, significantly reducing hospitalization ratesand total treatment costs. USPH's current stock valuepresents a favorable entry point, especially with market misconceptions aboutGLP-1 adoption impacting the physical therapy industry. Read the full article on Seeking Alpha

Previsioni di crescita degli utili e dei ricavi

NYSE:USPH - Stime future degli analisti e dati finanziari passati (USD Millions )
DataRicaviUtiliFlusso di cassa liberoLiquidità dell'operazioneAvg. Numero di analisti
12/31/202898156N/AN/A1
12/31/202789672831087
12/31/20268395768927
3/31/202678886784N/A
12/31/2025773226175N/A
9/30/2025751365770N/A
6/30/2025722356172N/A
3/31/2025692335666N/A
12/31/2024664286675N/A
9/30/2024639147382N/A
6/30/2024621166877N/A
3/31/2024606186675N/A
12/31/2023599187382N/A
9/30/2023585246472N/A
6/30/2023575266270N/A
3/31/2023564285058N/A
12/31/2022548295059N/A
9/30/2022536394857N/A
6/30/2022522385968N/A
3/31/2022509376170N/A
12/31/2021490316876N/A
9/30/2021477317886N/A
6/30/2021461308187N/A
3/31/20214183295101N/A
12/31/20204183292100N/A
9/30/2020423308291N/A
6/30/2020431317282N/A
3/31/2020473295565N/A
12/31/201947731N/A62N/A
9/30/201947230N/A65N/A
6/30/201946823N/A71N/A
3/31/201945718N/A71N/A
12/31/201844917N/A73N/A
9/30/201844218N/A70N/A
6/30/201843222N/A65N/A
3/31/201842121N/A58N/A
12/31/201741022N/A57N/A
9/30/201739220N/A53N/A
6/30/201737720N/A42N/A
3/31/201736321N/A51N/A
12/31/201635321N/A51N/A
9/30/201634820N/A48N/A
6/30/201634421N/A49N/A
3/31/201633721N/A49N/A
12/31/201532721N/A38N/A
9/30/201532021N/A45N/A
6/30/201531320N/A43N/A

Previsioni di crescita futura degli analisti

Guadagni vs tasso di risparmio: La crescita prevista degli utili di USPH ( 47.5% all'anno) è superiore al tasso di risparmio ( 3.5% ).

Guadagni vs Mercato: Si prevede che gli utili di USPH ( 47.5% all'anno) cresceranno più rapidamente del mercato US ( 17.1% all'anno).

Guadagni ad alta crescita: Si prevede che gli utili di USPH cresceranno in modo significativo nei prossimi 3 anni.

Ricavi vs Mercato: Si prevede che il fatturato di USPH ( 7.3% all'anno) crescerà più lentamente rispetto al mercato US ( 11.9% all'anno).

Ricavi ad alta crescita: Si prevede che il fatturato di USPH ( 7.3% all'anno) crescerà più lentamente di 20% all'anno.


Previsioni di crescita dell'utile per azione


Rendimento futuro del capitale proprio

ROE futuro: Dati insufficienti per determinare se il Return on Equity di USPH è previsto essere elevato tra 3 anni


Scoprire le aziende in crescita

Analisi aziendale e situazione dei dati finanziari

DatiUltimo aggiornamento (ora UTC)
Analisi dell'azienda2026/06/09 09:44
Prezzo dell'azione a fine giornata2026/06/09 00:00
Utili2026/03/31
Utili annuali2025/12/31

Fonti dei dati

I dati utilizzati nella nostra analisi aziendale provengono da S&P Global Market Intelligence LLC. I seguenti dati sono utilizzati nel nostro modello di analisi per generare questo report. I dati sono normalizzati, il che può comportare un ritardo nella disponibilità della fonte.

PacchettoDatiTempisticaEsempio Fonte USA *
Dati finanziari della società10 anni
  • Conto economico
  • Rendiconto finanziario
  • Bilancio
Stime di consenso degli analisti+3 anni
  • Previsioni finanziarie
  • Obiettivi di prezzo degli analisti
Prezzi di mercato30 anni
  • Prezzi delle azioni
  • Dividendi, scissioni e azioni
Proprietà10 anni
  • Top azionisti
  • Insider trading
Gestione10 anni
  • Team di leadership
  • Consiglio di amministrazione
Sviluppi principali10 anni
  • Annunci aziendali

* Esempio per i titoli statunitensi, per i titoli non statunitensi si utilizzano forme e fonti normative equivalenti.

Se non specificato, tutti i dati finanziari si basano su un periodo annuale ma vengono aggiornati trimestralmente. Si tratta dei cosiddetti dati TTM (Trailing Twelve Month) o LTM (Last Twelve Month). Per saperne di più.

Modello di analisi e Snowflake

I dettagli del modello di analisi utilizzato per generare questo report sono disponibili sulla nostra pagina Github; abbiamo anche guide su come utilizzare i nostri report e tutorial su Youtube.

Scoprite il team di livello mondiale che ha progettato e realizzato il modello di analisi Simply Wall St.

Metriche di settore e industriali

Le nostre metriche di settore e di sezione sono calcolate ogni 6 ore da Simply Wall St; i dettagli del nostro processo sono disponibili su Github.

Fonti analitiche

U.S. Physical Therapy, Inc. è coperta da 15 analisti. 7 di questi analisti ha fornito le stime di fatturato o di utile utilizzate come input per il nostro report. Le stime degli analisti vengono aggiornate nel corso della giornata.

AnalistaIstituzione
Michael PetuskyBarrington Research Associates, Inc.
Joanna Sylvia GajukBofA Global Research
Joseph FranceCantor Fitzgerald & Co.